Enoxaparin Sodium Injection requires deep subcutaneous injection for the treatment of unstable angina pectoris and non-Q-wave myocardial infarction, and is administered by the intravascular route in extracorporeal circulation for hemodialysis. Enoxaparin Sodium Injection can prevent the formation of venous thrombosis, and can be used after orthopedic surgery, general surgery and hemodialysis, but also for the treatment of deep vein embolism, unstable angina pectoris, non-Q-wave myocardial infarction, the use of which is related to the treatment of the disease, and can be administered by the deep subcutaneous injection and the intravascular route, and prohibited intramuscular injection. Enoxaparin sodium injection may be Xiaohu Zian bleeding, thrombocytopenia, hematoma at the injection site and other adverse reactions after use, allergy to the components of this product, active bleeding, cerebral hemorrhage and other patients are prohibited. Patients are advised to use the drug in strict compliance with medical advice.